Association between prostate cancer and mental health: A comparison across cancer types using the Medical Expenditure Panel Survey, 2017–2022.
Abstract
132 Background: Mental health is a critical yet often underrecognized dimension of cancer survivorship, influencing quality of life, treatment adherence, and long-term outcomes. This study evaluated whether men with prostate cancer (PCa) experience better mental health outcomes than those with other major cancers or no cancer, using nationally representative data. Methods: We conducted a repeated cross-sectional study using Medical Expenditure Panel Survey Household Component data (2017–2022). Respondents were categorized into three groups: PCa, other malignancies, and no history of cancer. The primary outcome was fair/poor self-rated mental health. Secondary outcomes included major depressive symptoms (PHQ-2 ≥ 3) and serious psychological distress (K6 ≥ 13). Multivariable logistic regression was employed to estimate adjusted odds ratios (aORs) with 95% confidence intervals, controlling for sociodemographic and health-related covariates. Results: Among 31,706 respondents (mean age 62.2 ± 10.9 years), most were non-Hispanic White (60.5%). Overall, 5.3% had PCa, 5.1% other cancers, and 89.6% no cancer (Table 1). In the primary analysis, 41.0% reported less-than-good self-rated mental health: 42.1% among PCa survivors, 40.4% among those without cancer, and 47.2% among individuals with other malignancies (p < 0.001). Compared with PCa, men without cancer had similar odds (aOR 0.96, 95% CI 0.85–1.09), while those with other cancers had higher odds (aOR 1.24, 95% CI 1.05–1.46), driven mainly by colorectal cancer (aOR 1.37, 95% CI 1.03–1.81). In secondary analyses, depressive symptoms (PHQ-2 ≥ 3) were reported by 7.3% of PCa survivors, 7.4% without cancer (aOR 0.98, 95% CI 0.76–1.27), and 8.6% with other cancers (aOR 1.21, 95% CI 0.87–1.68; p = 0.31). On the K6 scale, serious psychological distress was observed in 3.0% of PCa survivors and 3.7% of other groups (p = 0.47); colorectal cancer showed lower odds (aOR 0.12, 95% CI 0.02–0.86) and lymphoma higher (aOR 2.34, 95% CI 0.98–5.59). Conclusions: Mental health outcomes among PCa survivors were comparable to men without cancer and more favorable than in other malignancies. Nonetheless, over 40% reported suboptimal well-being, underscoring the need for integrated mental health screening and support across cancer populations. Mental health measures by cancer history. No history of cancer Prostate Non-prostate cancer Total Test N 28,405 (90.7) 1,690 (5.4) 1,611(5.1) 31,706(100.0) Overall Mental Health Status Below 'Good', n (%) No 16,931(59.6) 978 (57.9) 850(52.8) 18,759(59.2) <0.001 Yes 11,474(40.4) 712 (42.1) 761(47.2) 12,947(40.8) K6 Score 13 or higher, n (%) No 20,564(96.3) 1,255 (97.0) 1,192(96.3) 23,011(96.4) 0.473 Yes 782(3.7) 39 (3.0) 46(3.7) 867(3.6) Having Depression Symptom, n (%) No 20,004(92.6) 1,218 (92.7) 1,154(91.4) 22,376 (92.5) 0.308 Yes 1,599(7.4) 96 (7.3) 108(8.6) 1,803 (7.5)
Article Details
Journal Info
Journal of Clinical Oncology
Lippincott Williams & Wilkins
Authors (11)
Kamil Malshy
University of Rochester Medical Center, Rochester, NY
Yusheng Jia
Department of Health Services Research and Policy, University of Rochester Medical Center, Rochester, NY
Trevor C. Hunt
University of Rochester Medical Center, Rochester, NY
Denzel Zhu
Department of Urology, University of Rochester Medical Center, Rochester, NY
Melody Sun
Upstate Medical University, State University of New York, Syracuse, NY
Jaeuk Shin
Cornell University, Ithaca, NY
Matthew Steidle
Department of Urology, University of Rochester Medical Center, Rochester, NY
Ashley Li
University of Rochester Medical Center, Rochester, NY
Wenhan Guo
Department of Physics, University of Texas at El Paso 2 , El Paso, Texas 79902,
Jathin Bandari
University of Rochester Medical Center, Rochester, NY
Zijing Cheng
Department of Urology, University of Rochester Medical Center, Rochester, NY